Search Results 1091-1100 of 17811 for monoclonal antibody

  1. A Study to Evaluate the Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer - Mayo Clinic

    Has had a prior monoclonal antibody within 4 weeks prior to study Day 1 or ... antibody (including ipilimumab or any other antibody or drug ...

  2. COVID19 Immunology and Omics Study - Clinical Trials

    Individuals who are recieving a monoclonal antibody infusion. Participating Mayo Clinic locations. Study statuses change often. Please contact the study team ...

  3. Mayo Clinic Q&A - Dr. Gregory Poland - COVID-19 Update Audio...

    It significantly negated the value of some of our monoclonal antibodies. So ... So, the theory had been that these allergic reactions are mediated by an antibody ...

  4. Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma With Excess Glucocorticoid Production - Mayo Clinic

    - History of severe hypersensitivity to another monoclonal antibody - Other concurrent cancer or a history of another invasive malignancy within the last 3

  5. A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors - Mayo Clinic

    A Phase 1/2, First-in-Human, Open Label, Dose Escalation Study Of A CSP Targeting Functional Antibody in Solid Tumors. Print details. Share; Facebook · Twitter.

  6. Rabies immune globulin (intramuscular route) - Side effects & uses - Mayo Clinic

    Rabies immune globulin is used together with rabies vaccine to prevent infection caused by the rabies virus. It works by giving your body the antibodies it ...

  7. Cyclophosphamide, Carfilzomib, Thalidomide, and Dexamethasone in Treating Patients With Newly Diagnosed Active Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody therapy; Palliative radiation therapy is permitted if clinically indicated and not indicative of progressive disease. Participating Mayo ...

  8. Stopping Versus Continuation Of Long-term Mepolizumab In Severe Eosinophilic Asthma Patients - Mayo Clinic

    Other Monoclonal Antibodies: Subjects who have received any monoclonal antibody (other than XOLAIR®) to treat inflammatory disease within 5 half-lives of Visit ...

  9. Hepatocellular Carcinoma (HCC) Clinical Trials - Mayo Clinic Research

    The purpose of this study is to assess the efficacy and safety of tiragolumab, an anti-TIGIT monoclonal antibody, when administered in combination with ...

  10. A Study Of IBI363 In Subjects With Advanced Solid Malignancies - Mayo Clinic

    ... monoclonal antibody (mAb) within 4 weeks prior to first dose 3. Received live vaccines within 28 days prior to first administration of the study drug or ...